Abstract Body

Changes in human oral microbiota have been linked to diseases of aging that are common in HIV, including atherosclerosis and certain cancers. Oral pathology, including thrush, oral hairy leukoplakia and periodontal disease, is common in chronic HIV infection. HIV has been associated with shifts in the microbiome at several sites, although no studies have longitudinally assessed oral microbiome change in the setting of controlled ART initiation. Here, we characterize the oral bacterial microbiome before and after 24 weeks of ART.

Thirty-five participants co-enrolled in two ACTG studies, A5272 and A5280, were assessed. All participants were ART-naïve at baseline and received EFV/FTC/TDF in A5280. Saliva was collected as part of A5272. Paired saliva samples from both studies were evaluated for bacterial microbiome using 16S rDNA PCR followed by Illumina sequencing. Reads were analyzed using QIIME. Operational taxonomic units (OTUs) were assigned, and differences in distribution and abundance before and after ART were assessed.

At entry, median age was 35 years; (89% male; 46% white, 31% African American, 20% Hispanic). Median CD4 count was 326 cells/mm3 (range: 7-804); 5 participants had CD4 counts <200 cells/mm3. Median viral load was 30,136 cp/mL; 9 participants had viral load >100,000 cp/mL. All participants suppressed on EFV/FTC/TDF to HIV VL<200, although one rebounded at week 24 after suppression. No significant change was seen between baseline and week 24 samples in either alpha or beta diversity (p>0.05 for both). Overall, the distribution of OTUs in the oral samples remained similar at weeks 0 and 24. However, participants with CD4<200 cells/mm3 had fewer Firmicutes, Actinobacteria, Bacteroidetes, and Fusobacteria, and more Proteobacteria, than those with CD4>200 cells/mm3. Importantly, these differences persisted at week 24 of ART.

In this prospective study of ART naïve individuals, we identified relative stability within the oral microbiome after 24 weeks of ART. However, persons with advanced HIV disease had greater representation of the phylum Proteobacteria, which has also been reported in the gut microbiome of persons with advanced HIV disease. This shift to a greater representation of pathogenic Gram-negative bacteria is a potential contributor to excess inflammation in the setting of advanced disease, and is not completely reversed by 24 weeks of effective ART.